Skip to main content
. Author manuscript; available in PMC: 2014 Sep 24.
Published in final edited form as: ACS Nano. 2013 Aug 20;7(9):7724–7733. doi: 10.1021/nn4023119

Figure 5.

Figure 5

Biodistribution of DOX-SPIOs following administration in N1S1 model. Animals in the nano-ablation group demonstrated significantly higher DOX-SPIO uptake within tumor tissue, as well as decreased uptake within healthy liver and spleen tissue, compared to controls (p<0.05).

HHS Vulnerability Disclosure